FPX Nickel Gets C$14.5 Million Investment from Sumitomo Metal Mining for 9.9% Interest
By Adriano Marchese
FPX Nickel said Wednesday that it has received a 14.5 million Canadian dollar ($10.7 million) investment from Japanese metals miner and producer Sumitomo Metal Mining for a 9.9% stake.
The Canadian nickel producer said it will issue 30.1 million shares to Sumitomo Metal Mining Canada, the subsidiary of Sumitomo Metal Mining, at a price of C$0.48 a share.
The offer price is a premium to FPX's current share price. Shares have been under pressure in the last 12 months, falling nearly 21% and closing at C$0.33 on Tuesday.
FPX said it intends to use the proceeds of the investment to advance its exploration and development activities at its flagship facility in central British Columbia.
Based on the company's preliminary feasibility study completed in 2023, Baptiste has the potential to produce an average of 59,100 metric tons of nickel a year over a projected mine life of 29 years.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
January 17, 2024 07:31 ET (12:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
3 Stocks With High Dividend Yields That Warren Buffett Likes
-
How to Invest Like Warren Buffett
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?